Clinical Trials With Soluble Collagen Reported
"Properly modified animal collagen shows great potential as an ideal human biomaterial," Albert L. Rubin, MD, said in the first report of clinical trials with soluble collagen.
Dr. Rubin discussed early clinical experience using animal collagen for replacement of the vitreous humor and for dialysis membranes at the American Association for the Advancement of Science meeting in Boston. The material also shows promise for the reinforcement and replacement of arteries, heart valves, and corneal surfaces.
Dr. Rubin, professor of biochemistry and surgery at Cornell University Medical College, emphasized the preliminary nature of the collagen studies. Coauthor of the paper is Kurt H. Stenzel, MD, associate professor of biochemistry and surgery at Cornell.
Twelve patients who had retinal detachments previously considered inoperable have been followed only three months, said Charles L. Scheppens, MD. Dr. Scheppens, associate clinical professor of ophthalmology at Harvard Medical School
. . . [Full Text PDF of this Article]
